Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting
- PMID: 20508174
- PMCID: PMC3374378
- DOI: 10.1182/blood-2010-01-265728
Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting
Comment on
-
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.Blood. 2010 Feb 4;115(5):1098-105. doi: 10.1182/blood-2009-03-207563. Epub 2009 Nov 19. Blood. 2010. PMID: 19965688 Free PMC article. Clinical Trial.
References
-
- Khuu T, Shayani S, Palmer J, et al. Thrombotic microangiopathy with tacrolimus/sirolimus-based GVHD prophylaxis regimen in patients undergoing hematopoietic stem cell transplant from a matched unrelated donor [abstract]. Blood. 2008;112(11) Abstract 797.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
